Omnicell (OMCL) Notes Payables (2021 - 2025)

Omnicell's (OMCL) quarterly Notes Payables came in at $174.8 million in Q2 2025, little changed on a QoQ basis from $174.6 million in Q1 2025.

Omnicell (OMCL) Notes Payables (2021 - 2025) Analysis & Trends

Omnicell (OMCL) has 4 years of Notes Payables data on file, last reported at $174.8 million in Q2 2025.

  • On a quarterly basis, Notes Payables changed N/A year-over-year to $174.8 million in Q2 2025; TTM through Jun 2025 was $174.8 million, a N/A change from a year earlier, with the FY2024 full-year figure at $174.3 million, changed N/A from the prior year.
  • Notes Payables for Q2 2025 stood at $174.8 million, roughly flat from $174.6 million in the prior quarter.
  • Over the last five years, Notes Payables for OMCL reached as high as $572.0 million in Q3 2024 and fell as low as $174.3 million in Q4 2024.
  • Historically, Notes Payables has averaged $358.0 million across 4 years, with a median of $331.5 million in 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 29.34 Bn 22.03 Bn 662.02 Mn
2 BrightSpring Health Services 13.49 Bn 12.59 Bn 482.22 Mn
3 Healthequity 7.96 Bn 7.70 Bn 256.31 Mn
4 10x Genomics 6.17 Bn 5.63 Bn 106.18 Mn
5 Hinge Health 6.02 Bn 5.70 Bn 154.23 Mn
6 MiniMed 4.19 Bn 3.89 Bn 480.00 Mn
7 Waystar Holding 4.14 Bn 4.07 Bn 216.84 Mn
8 Doximity 3.82 Bn 3.08 Bn 125.97 Mn
9 Privia Health 3.10 Bn 2.73 Bn -
10 Omnicell 1.81 Bn 1.57 Bn 140.36 Mn

Historic Data

Download Data
DateValue
Jun 30, 2025 174.80 Mn
Mar 31, 2025 174.56 Mn
Dec 31, 2024 174.32 Mn
Sep 30, 2024 572.00 Mn
Mar 31, 2022 564.27 Mn
Dec 31, 2021 488.15 Mn